The ASP chairs are happy to publish the MUHC ASP annual report 2024-2025, now available in the Resources section of the MUHC ASP website. The report contains several key information and analysis on the usage and cost of antimicrobial in the MUHC and the most recent antibiogram for targeted bacteria. We hope you will enjoy the report and will be happy to answers any questions on it! Dr. Makeda Semret, Lead of Antimicrobial Stewardship Program François Bourdeau, Co-Chair of Ant

Each year, World Antimicrobial Resistance Awareness Week reminds us of the importance of using these essential medications responsibly. Antimicrobial resistance—when bacteria and other microorganisms are no longer killed by antimicrobials—is a growing threat to public health worldwide. At the McGill University Health Centre (MUHC), the Antimicrobial Stewardship Program (ASP) is at the heart of the fight against this phenomenon. Its goal is to ensure the safe, effective, and

The ASP committee is happy to make available the new guide IV to PO! It covers situation in which a switch to PO is indicated for certain...

The MUHC ASP website has gone through a re-do: combination of spring cleaning and cosmetic changes, but keeping all the content! check...

INESSS approved the TDM of Linezolid in May 2024 It is now available in the MUHC (via HSJ labs) The ASP committee is happy to publish a...

The ASP chairs are happy to publish the MUHC ASP annual report 2022-2023, now available in the Resources section of the MUHC ASP website....

The ASP committee is happy to give you an early Christmas gift! We published the guidelines on management and treatment of Staphylococcus...

ASP committee developed a post-exposure prophylaxis (HIV, hepB & hepC) guidelines in collaboration with the CVIS team. It is available on...

The ASP committee updated the COVID guidelines. You will find the following change: -Removal of the pre-exposure prophylaxis guidelines...

Correction made for Heart transplant and Lung transplant recipients: both anti-mold AND anti-PJP prophylaxis recommended.

To MUHC users: Please note that as of Dec 5, 2022, requests for outpatient antiviral management of COVID-19 for HIGH RISK patients should...

The MUHC ASP committee is happy to announce the update and publication of several guidelines: Pre-exposure prophylaxis to COVID :...

The ASP group is happy to announce the update to the MUHC UTI guidelines! It includes updated MUHC urine culture antibiogram, most...

The ASP Committee is happy to upload the following guidelines to the MUHC ASP website: -COVID guidelines V11 and Outpatient COVID...

Do you wonder how to treat an aspiration pneumonia? What antibiotic to give in case of an open fracture? Should you give Vancomycin for...

Oral antiviral therapy (nirmatrelvir/ritonavir or Paxlovid) is now available in Quebec for selected patients who are at high risk of...

Are you struggling trying to decide which of your COVID-19 patients may be candidates for MAb? Keenly aware these products are in...

In anticipation of a possible surge in hospitalizations and taking into account recent evidence, (and limited supplies of some...

MUHC Management of suspected/confirmed COVID-19 in adults guideline has been updated! Available at https://www.muhcasp.com/treatment-guid...

Hi all, The ASP team is proud to announce the publication of the following five guidelines on the management of fungal infections :...